Description of Collaborative Activity: |
The CMS-FDA-NIH Trilateral Council provides a forum for agency leaders to discuss policy issues, programs, and research initiatives of mutual interest and determines appropriate interfaces and collaborations that may inform NIH-funded research, FDA guidance and regulations, and CMS policies and programs. The Council formed in April 2016 and meets at the request of the Chairs: the NIH Director, FDA Commissioner, and CMS Administrator. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|
